GXP-PHARMA SUPPORT A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About GXP-PHARMA SUPPORT A/S
GXP-PHARMA SUPPORT A/S (CVR number: 36033347) is a company from SORØ. The company recorded a gross profit of -262.8 kDKK in 2024. The operating profit was -347.8 kDKK, while net earnings were -166.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -19.1 %, which can be considered poor and Return on Equity (ROE) was -22 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 57.8 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. GXP-PHARMA SUPPORT A/S's liquidity measured by quick ratio was 2.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 1 000.08 | 382.15 | 211.19 | 360.87 | - 262.79 |
EBIT | 24.57 | 152.87 | -58.41 | 126.74 | - 347.77 |
Net earnings | 664.08 | 425.67 | - 345.55 | 367.36 | - 166.43 |
Shareholders equity total | 1 692.20 | 1 117.87 | 772.32 | 1 139.68 | 373.25 |
Balance sheet total (assets) | 3 975.61 | 2 176.66 | 1 104.59 | 1 480.58 | 646.16 |
Net debt | -1 205.57 | -1 005.13 | - 746.97 | -1 142.74 | - 480.22 |
Profitability | |||||
EBIT-% | |||||
ROA | 25.3 % | 18.1 % | -2.4 % | 36.7 % | -19.1 % |
ROE | 42.6 % | 30.3 % | -36.6 % | 38.4 % | -22.0 % |
ROI | 29.0 % | 22.0 % | -3.2 % | 44.8 % | -23.6 % |
Economic value added (EVA) | 81.03 | 179.13 | -23.48 | 101.59 | - 264.68 |
Solvency | |||||
Equity ratio | 42.6 % | 51.4 % | 69.9 % | 77.0 % | 57.8 % |
Gearing | 99.7 % | 49.9 % | 10.3 % | 11.3 % | 21.0 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.7 | 2.1 | 3.3 | 4.3 | 2.4 |
Current ratio | 1.7 | 2.1 | 3.3 | 4.3 | 2.4 |
Cash and cash equivalents | 2 893.04 | 1 563.12 | 826.62 | 1 271.04 | 558.58 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BB |
Variable visualization
Roles
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.